Skip to main content

Advertisement

Log in

Effect of heating temperature and time on pharmaceutical characteristics of albumin microspheres containing 5-fluorouracil

  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Conclusion

In this study, we found that both heating temperature and heating time affect mean particle size, particle size distribution, and drug entrapment efficiency of albumin microspheres. The change in heating temperature may affect the particle size of the product, especially when heating is carried out at a lower temperature (90°C–120°C). Hence the temperature should be selected on the basis of desired size range. Given that it is desirable for a maximum amount of the drug used in the preparation to become entrapped in microspheres, heating temperature and heating time for denaturation of albumin should be selected cautiously, as both have a significant effect on drug entrapment efficiency. In the present case, the highest entrapment was found in batches prepared by heating at 90°C for 5 minutes. However, the extent of stabilization at the selected temperature and the time of heating should also be taken into consideration, as they may affect the release of drugs to target tissue.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kato T. Encapsulated drug in targeted cancer therapy. In: Bruck SD, ed. Controlled Drug Delivery. Vol 2. Clinical Applications. Boca Raton, Florida: CRC Press, 1983:189–240.

    Google Scholar 

  2. Truter EJ. Heat-stabilized albumin microspheres as a sustained drug delivery system for the antimetabolite, 5-fluorouracil. Artif Cells Blood Substit Immobil Biotechnol. 1995;23(5):579–586.

    Article  PubMed  CAS  Google Scholar 

  3. Arshady R. Albumin microspheres and microcapsules: methodology of manufacturing techniques. J Control Release. 1990; 14:111–131.

    Article  CAS  Google Scholar 

  4. Burger JJ, Tomlinson E, Mulder EMA, McVie JG. Albumin microspheres for intra-arterial tumour targeting, I: pharmaceutical Aspects. Int J Pharm. 1985;23:333–344.

    Article  CAS  Google Scholar 

  5. Zeng XM, Martin GP, Marriott C. Albumin microspheres as a means of drug delivery to the lung: analysis of the effects of process variables on particle sizes using factorial design methodology. Int J Pharm. 1994;107:205–210.

    Article  CAS  Google Scholar 

  6. Ishizaka T, Endo K, Koishi M. Preparation of egg albumin microcapsules and micropheres. J Pharm Sci. 1981;70(4):353–363.

    Article  Google Scholar 

  7. Chabner BA, Allegra CJ, Curt GA, Calabresi P. Antineoplastic agents. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG, ed. Goodman & Gilmans The Pharmacological Basis of Therapeutics. 9th ed. McGraw Hill; 1955:1233–1288.

  8. Kumar V, Banker GS. Target-oriented drug delivery systems. In: Banker GS, Rhodes CT, eds. Modern Pharmaceutics. 3rd ed. New York, NY: Marcel Dekker, 1995:611–680.

    Google Scholar 

  9. Truter EJ, Santos AS, Els WJ. Assessment of the antitumour activity of targeted immunospecific albumin microspheres loaded with cisplatin and 5-fluouracil: toxicity against a rodent ovarian carcinoma in vitro. Cell Biol Int. 2001;25(1):51–59.

    Article  PubMed  CAS  Google Scholar 

  10. Gupta PK, Hung CT, Lam FC, Perrier DG. Albumin microspheres, III: synthesis and characterization of microspheres containing adriamycin and magnetite. Int J Pharm. 1988;43:167–177.

    Article  CAS  Google Scholar 

  11. Sheu MT, Moustafa MA, Sokoloski TD. Entrapment of bioactive compound within native albumin beads, II: effect of rate and extent of cross linking on microbead properties. J Parent Sci Tech. 1986;40(6):253–258.

    CAS  Google Scholar 

  12. Karunakaran S, Singh J. Preparation, characterization and in vitro release kinetics of salbutamol sulphate loaded albumin microspheres. Drug Dev Ind Pharm. 1994;20(8):1377–1399.

    Article  Google Scholar 

  13. Gallo JM, Hung CT, Perrier DG. Analysis of albumin microsphere preparation. Int J Pharm. 1984;22:63–74.

    Article  CAS  Google Scholar 

  14. Yapel AF Jr. Albumin microspheres: heat and chemical stabilization. Methods in Enzymology. 1985;112:3–18.

    Article  CAS  Google Scholar 

  15. Kim CK, Oh YK. Development of hydrophilic human serum albumin microspheres using a drug-albumin conjugate. Int J Pharm. 1988;47:163–169.

    Article  CAS  Google Scholar 

  16. Gupta PK, Hung CT, Perrier DG. Albumin microspheres, I: release characteristics of adriamycin. Int J Pharm. 1986;33:137–146.

    Article  CAS  Google Scholar 

  17. Gupta PK, Hung CT, Perrier DG. Albumin microspheres, II: effect of stabilization temperature on the release of adriamycin. Int J Pharm. 1986;33:147–153.

    Article  CAS  Google Scholar 

  18. Bertucci C, Ascoli G, Uccello-Barretta G, Di Bari L, Salvadori P. The binding of 5-fluorouracil to native and modified human serum albumin: UV, CD, and 1H and 19F NMR investigation. J Pharm Biomed Anal. 1995;13(9):1087–1093.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rajesh R. Dubey.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dubey, R.R., Parikh, J.R. & Parikh, R.R. Effect of heating temperature and time on pharmaceutical characteristics of albumin microspheres containing 5-fluorouracil. AAPS PharmSciTech 4, 4 (2003). https://doi.org/10.1208/pt040104

Download citation

  • Received:

  • Accepted:

  • DOI: https://doi.org/10.1208/pt040104

Keywords

Navigation